I'm not sure if the poll, if actually taken by whoever, Flavus, etc., has any credibility at all.
I think it is important to note that there are no restrictions on who can get the medication if they have failed 1 treatment. They could have failed more than 2 or 3 or 4, and have other issues that would have precluded them from participating even in the pona registration trial. There could be many "hail Mary" patients out there, desperate, but sadly cannot be helped even by this miracle drug.
Can you imagine how much more poorly these patients would have done on Gleevec, or Tasigna or Sprycel, or bono? It is likely they already failed 3 or 4 of them. There is no accountability in this so called 'poll' of the nature of the treatment history of these patients.
Market Data 
Markets 
AI
